Evidence map›Paper›PMID 33092584›Full record

ArticleJournal of nanobiotechnology2020

Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer.

María Sancho-Albero, Víctor Sebastián, Javier Sesé, Roberto Pazo-Cid, Gracia Mendoza, Manuel Arruebo, Pilar Martín-Duque, Jesús Santamaría

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Single-Cell Nucleus Extraction with Cellular Indexing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Review
  5. Review
  6. Basic Guide for Approaching Drug Delivery with Extracellular Vesicles.International journal of molecular sciences · 2024
    Review
  7. Therapeutic Potential of Bovine Milk-Derived Extracellular Vesicles.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Engineering of Cell Derived-Nanovesicle as an Alternative to Exosome Therapy.Tissue engineering and regenerative medicine · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

María Sancho-AlberoDepartment of Chemical Engineering, University of Zaragoza, 50018, Zaragoza, Spain.
Víctor SebastiánDepartment of Chemical Engineering, University of Zaragoza, 50018, Zaragoza, Spain. victorse@unizar.es.
Javier SeséInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009, Zaragoza, Spain.
Roberto Pazo-CidMedical Oncology Service, Miguel Servet Hospital, 50009, Zaragoza, Spain.
Gracia MendozaNetworking Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, 28029, Madrid, Spain.
Manuel ArrueboDepartment of Chemical Engineering, University of Zaragoza, 50018, Zaragoza, Spain.
Pilar Martín-DuqueNetworking Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, 28029, Madrid, Spain. mpmartind.iacs@aragon.es.ORCID http://orcid.org/0000-0003-4160-9720
Jesús SantamaríaDepartment of Chemical Engineering, University of Zaragoza, 50018, Zaragoza, Spain.
Universidad de Zaragoza · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESFundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ESHospital Universitario Miguel Servet · ES

Funding

European Research Council ERC-2016-ADG-742684, CADENCEGobierno de Aragón T57_17R pInstituto de Salud Carlos III PI19/01007
6 · The paper itself

Abstract

backgroundExosomes are endocytic-extracellular vesicles with a diameter around 100 nm that play an essential role on the communication between cells. In fact, they have been proposed as candidates for the diagnosis and the monitoring of different pathologies (such as Parkinson, Alzheimer, diabetes, cardiac damage, infection diseases or cancer).

resultsIn this study, magnetic nanoparticles (Fe

conclusionsHere, we describe a new microfluidic device and the procedure for the isolation of exosomes from whole blood, without any need of previous isolation steps, thereby facilitating translation to the clinic. The results show that, for the cases analyzed, the evaluation of CA19-9 in exosomes was highly sensitive, compared to serum samples.

Indexed as

AntibodiesAntigens, Tumor-Associated, CarbohydrateBlood Chemical AnalysisBoronElectromagnetic FieldsExosomesHumansIronLab-On-A-Chip DevicesMagnetite NanoparticlesNeodymiumPancreatic NeoplasmsSurface PropertiesAntibodiesAntigens, Tumor-Associated, CarbohydrateBoroncarbohydrate antigen 199, humanIronMagnetite NanoparticlesNeodymiumExosomesMagnetic captureMicrofluidics and pancreatic cancer

Identifiers

PMID33092584
PMCPMC7579907
OpenAlexW3094523892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.